WO2005085285A3 - Nuclear hormone receptors - Google Patents
Nuclear hormone receptors Download PDFInfo
- Publication number
- WO2005085285A3 WO2005085285A3 PCT/GB2005/000801 GB2005000801W WO2005085285A3 WO 2005085285 A3 WO2005085285 A3 WO 2005085285A3 GB 2005000801 W GB2005000801 W GB 2005000801W WO 2005085285 A3 WO2005085285 A3 WO 2005085285A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lowbar
- hormone receptors
- nuclear hormone
- proteins
- q9bz29
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0404929.2 | 2004-03-04 | ||
GB0404929A GB0404929D0 (en) | 2004-03-04 | 2004-03-04 | Protein |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005085285A2 WO2005085285A2 (en) | 2005-09-15 |
WO2005085285A3 true WO2005085285A3 (en) | 2006-04-27 |
Family
ID=32088736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/000801 WO2005085285A2 (en) | 2004-03-04 | 2005-03-04 | Nuclear hormone receptors |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0404929D0 (en) |
WO (1) | WO2005085285A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001069507A2 (en) * | 2000-03-14 | 2001-09-20 | Inpharmatica Limited | Proteomics database |
WO2002007557A2 (en) * | 2000-07-20 | 2002-01-31 | L-3 Communications Integrated System L.P. | Substantially noiseless fastening systems for carrying packs and apparel |
WO2003045321A2 (en) * | 2001-11-26 | 2003-06-05 | Exelixis, Inc. | MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
WO2004003018A1 (en) * | 2002-07-01 | 2004-01-08 | Inpharmatica Limited | Nuclear hormone receptor |
WO2005016962A2 (en) * | 2003-08-11 | 2005-02-24 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
-
2004
- 2004-03-04 GB GB0404929A patent/GB0404929D0/en not_active Ceased
-
2005
- 2005-03-04 WO PCT/GB2005/000801 patent/WO2005085285A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001069507A2 (en) * | 2000-03-14 | 2001-09-20 | Inpharmatica Limited | Proteomics database |
WO2002007557A2 (en) * | 2000-07-20 | 2002-01-31 | L-3 Communications Integrated System L.P. | Substantially noiseless fastening systems for carrying packs and apparel |
WO2003045321A2 (en) * | 2001-11-26 | 2003-06-05 | Exelixis, Inc. | MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
WO2004003018A1 (en) * | 2002-07-01 | 2004-01-08 | Inpharmatica Limited | Nuclear hormone receptor |
WO2005016962A2 (en) * | 2003-08-11 | 2005-02-24 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
Non-Patent Citations (5)
Title |
---|
"Biopendium", 19 December 2003, XP002346479 * |
BOURGUET W ET AL: "Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 21, no. 10, 1 October 2000 (2000-10-01), pages 381 - 388, XP004237263, ISSN: 0165-6147 * |
HASEGAWA H ET AL: "DOCK180, A MAJOR CRK-BINDING PROTEIN, ALTERS CELL MORPHOLOGY UPON TRANSLOCATION TO THE CELL MEMBRANE", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 16, no. 4, April 1996 (1996-04-01), pages 1770 - 1776, XP000985302, ISSN: 0270-7306 * |
JAN C ET AL: "Sequence annotation of nuclear receptor ligand-binding domains by automated homology modeling", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 13, no. 6, 2000, pages 391 - 394, XP002959343, ISSN: 0269-2139 * |
LI YONG ET AL: "Activation of nuclear receptors: A perspective from structural genomics.", STRUCTURE (CAMBRIDGE), vol. 11, no. 7, July 2003 (2003-07-01), pages 741 - 746, XP002344943, ISSN: 0969-2126 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005085285A2 (en) | 2005-09-15 |
GB0404929D0 (en) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX353319B (en) | Compositions and methods relating to glucagon receptor antibodies. | |
HK1103746A1 (en) | Antibodies to erythropoietin receptor and uses thereof | |
MY187263A (en) | Il-17 reception a antigen binding proteins | |
PL1972637T3 (en) | huTNFR1 selective antagonists | |
EP1398029A8 (en) | NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives | |
IL169367A0 (en) | Defensin proteins | |
WO2006046072A3 (en) | VWFA AND/OR ANT_IG DOMAIN CONTAINING PROTEINS | |
WO2004096856A3 (en) | Secreted protein family | |
WO2005085285A3 (en) | Nuclear hormone receptors | |
WO2002070557A3 (en) | Nuclear hormone receptor ligand binding domain | |
GB0423126D0 (en) | Protein | |
WO2004005346A3 (en) | Human nuclear hormone receptor | |
WO2004003010A3 (en) | Nuclear hormone receptor ligano-binding domain containing protein | |
WO2002070561A3 (en) | Nuclear hormone receptor ligand binding domain | |
WO2004101618A3 (en) | Progestin-yol002c-cgi-45 receptor-related proteins | |
WO2007068913A3 (en) | SRCR-B Domain Containing Proteins | |
WO2004009633A8 (en) | Serotonin receptor | |
WO2004081563A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a) | |
GB0426960D0 (en) | TGR-3 like protein receptor | |
WO2004000882A3 (en) | Proteins | |
WO2007049062A3 (en) | Vwfa-domain containing proteins | |
WO2004003011A3 (en) | Nuclear hormone receptor | |
ATE397755T1 (en) | DIAGNOSTICS AND THERAPY METHODS OF DOPAMINE RECEPTOR D3 (DRD3) ASSOCIATED ILLNESSES | |
WO2004097422A3 (en) | Diagnostics and therapeutics for diseases associated with calcitonin receptor (calcr) | |
WO2008017831A8 (en) | Secreted vit domain containing proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |